PRESS RELEASE: announces the appointment of Cédric Garnier as Managing Director.

Montbonnot, France – October 14, 2025 – TECHNIDATA SAS, an international provider of laboratory information systems (LIS, LMS), announces the appointment of Cédric Garnier as Chief Executive Officer, succeeding Olivier De Korte. Part of the TSS (Total Specific Solutions) Group – the European subsidiary of Constellation Software – TECHNIDATA is a leading player in in vitro diagnostics, with a presence in Europe, Asia, and North America. For over 40 years, the company has supported medical testing laboratories and healthcare facilities in their digital transformation. With extensive experience in digital health, combining management, innovation, and digital transformation, Cédric Garnier will be tasked with strengthening TECHNIDATA’s position in its established markets, while accelerating the modernization of its products, services, and internal tools. His roadmap is a continuation of the project initiated by the TSS Group: clarifying the offering, enhancing the clarity of the product ranges, simplifying processes, and establishing a culture of operational excellence to serve laboratories and healthcare facilities. “TECHNIDATA has a unique technological heritage and passionate teams. My ambition is to harness this collective energy around a clear vision: to offer increasingly high-performing, interoperable, and user-centric solutions,” explains Cédric Garnier, CEO of TECHNIDATA SAS. Othman Ghannam, Group Leader of the TSS Group, adds: “I am delighted that Cédric is taking the helm at TECHNIDATA. With his extensive experience in healthcare software and his in-depth market knowledge, he will be able to inject new momentum and support the company in carrying out ambitious projects. I am convinced that this appointment will also contribute to the development of the TSS Group’s Healthcare division in France.” “This appointment marks a new stage in the development of TECHNIDATA, which will leverage the synergies of the TSS Group to consolidate its leadership in the in vitro diagnostic medical software sector.” [custom-html]